Back
Vor Biopharma 10K Form
Sell
37
VOR
Vor Biopharma
Last Price:
1.81
Seasonality Move:
-10.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-25 | 10K | VOR/Vor Biopharma Annual |
Receive VOR News And Ratings
See the #1 stock for the next 7 days that we like better than VOR
VOR Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-30.58M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.80 |
| Price / Book: | 1 |
Profitability
| EPS (TTM): | -1.77000 |
|---|---|
| Net Income (TTM): | $-120.23M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Vor Biopharma Earnings Forecast
Key Vor Biopharma Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Vor Biopharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VOR |
| Website: | vorbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VOR Technical Analysis vs Fundamental Analysis
Sell
37
Vor Biopharma (VOR)
is a Sell
Is Vor Biopharma a Buy or a Sell?
-
Vor Biopharma stock is rated a Sell
The current Vor Biopharma [VOR] share price is $1.81. The Score for VOR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.